Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lusher

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Military Medicine|July 1, 1972
The detection of sickle cell hemoglobin in large human populations by an automated techniqueR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USAR Kulkarni, K P Ponder, A H James, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 23, 2010
Fibrinolytic parameters in children with noncatheter thrombosis: a pilot studyO Alphan Kupesiz, Meera B Chitlur, Wendy Hollon, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia BA D Shapiro, M V Ragni, J M Lusher, et al.
American Journal of Hematology|January 1, 1980
Essential thrombocythemia in a child: platelet ultrastructure and functionM I Barnhart, T H Kim, B L Evatt, et al.
Neurology|July 13, 2000
Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutationK D White, P G Ince, M Lusher, et al.
Blood|April 1, 1994
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study GroupP M Mannucci, D B Brettler, L M Aledort, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
North American study of factor VIII concentrate potencyJ M Lusher, F A Ofosu, J R Edson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
Thrombosis and Haemostasis|March 1, 2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigationWolfhart Kreuz, Joan C Gill, Chantal Rothschild, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Military Medicine|July 1, 1972
The detection of sickle cell hemoglobin in large human populations by an automated techniqueR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USAR Kulkarni, K P Ponder, A H James, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 23, 2010
Fibrinolytic parameters in children with noncatheter thrombosis: a pilot studyO Alphan Kupesiz, Meera B Chitlur, Wendy Hollon, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia BA D Shapiro, M V Ragni, J M Lusher, et al.
American Journal of Hematology|January 1, 1980
Essential thrombocythemia in a child: platelet ultrastructure and functionM I Barnhart, T H Kim, B L Evatt, et al.
Neurology|July 13, 2000
Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutationK D White, P G Ince, M Lusher, et al.
Blood|April 1, 1994
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study GroupP M Mannucci, D B Brettler, L M Aledort, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
North American study of factor VIII concentrate potencyJ M Lusher, F A Ofosu, J R Edson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
Thrombosis and Haemostasis|March 1, 2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigationWolfhart Kreuz, Joan C Gill, Chantal Rothschild, et al.
Pageof 18